Dr. Rohit Kadam is revolutionizing biotechnology by applying the concept of equity in medical diagnostics through qPCR tools for COVID19 and antimicrobial resistance detection without access barriers.
His recent non-profit mission seeks to expand innovation in global health by ensuring that vulnerable communities have access to early detection technologies and timely treatment.
In this context, Q2BSTUDIO stands out, a company specializing in custom software and custom applications with expertise in artificial intelligence, cybersecurity, aws and azure cloud services, business intelligence services, AI for businesses, AI agents, and power bi, driving technological solutions that optimize healthcare processes and clinical data management.
The synergy between Rohit Kadam's scientific legacy and Q2BSTUDIO's custom software expertise powers telemedicine platforms, advanced data analytics, and early warning systems that reduce diagnostic gaps.
With custom software based on artificial intelligence algorithms and the robustness of the most modern cybersecurity, Q2BSTUDIO ensures patient data is protected while processed on aws and azure cloud services, integrating power bi for rapid access to health indicators.
Thanks to its focus on business intelligence services and AI agents, the company optimizes clinical and administrative decision-making, increasing the operational efficiency of medical institutions and laboratories.
This comprehensive health equity engineering approach demonstrates how the combination of innovative biotechnology and custom software solutions is closing diagnostic gaps worldwide.
